Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × Antilymphocyte Serum × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Lymphoma, Non-Hodgkin 1 Leukemia, Biphenotypic, Acute 1 Lambert-Eaton Myasthenic Syndrome 1 Hemoglobinuria, Paroxysmal 1 Congenital amegakaryocytic thrombocytopenia 1 Bone Marrow Failure Disorders 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1 Anemia, Hypochromic 1 Anemia, Diamond-Blackfan 1

Interventions

Rituximab 25 Cyclophosphamide 23 Lenalidomide 20 Prednisone 11 fludarabine 10 Vincristine 10 Doxorubicin 10 obinutuzumab 8 Bendamustine Hydrochloride 8 zanubrutinib 7 Specimen Handling 7 Magnetic Resonance Spectroscopy 7 tazemetostat 6 fludarabine phosphate 6 Biopsy 6 R-CHOP protocol 4 ibrutinib 3 Therapeutics 3 Radiotherapy 3 Exercise 3 Cyclosporine 3 venetoclax 2 tislelizumab 2 tisagenlecleucel 2 pirtobrutinib 2 copanlisib 2 axicabtagene ciloleucel 2 Whole-Body Irradiation 2 Temozolomide 2 Standard of Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡